xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.authorArtikkelit"Zanchetti A"

Age-related effects of placebo and active treatment in patients beyond the age of 60 years: the need for a proper control group

Thijs L; Amery A; Birkenhäger W; Bulpitt CJ; Clement D; De Leeuw P; De Schaepdryver A; Dollery C; Forette F; Henry J; Koistinen A; Leonetti G; Nissinen A; O'Brien E; O'Malley K; Staessen J; Tuomilehto J; Webster J; Williams B; Zanchetti A
J Hypertens (1990)

An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization

Amery A; Beard K; Berthaux P; Birkenhäger W; Bogaert M; Brixko P; Bulpitt C; Chellappah M; Clement D; De Leeuw P; De Padua F; De Plaen JF; Deruyttere M; De Schaepdryver A; Fagard R; Feltkamp H; Forette F; Forte J; Hamdy R; Henry JF; Koistinen A; Konrads A; Leonetti G; Lund-Johansen P; Meagher F; Meurer K; Morris J; Murphy M; Mutsers A; Nissinen A; O'Brien E; Ohm OJ; O'Malley K; Pelemans W; Pereira-Miguel JM; Petrie J; Tuomilehto J; van Ypersele C; Webster J; Willemse P; Williams BO; Zanchetti A
ARCH INT PHARMACODYN THER (1985)

Characteristics of 15 314 hypertensive patients at high coronary risk. The VALUE Trial

Kjeldsen SE; Julius S; Brunner H; Hansson L; Henis M; Ekman S; Laragh J; McInnes G; Smith B; Weber M; Zanchetti A; VALUE Trial Group; Tuomilehto J
BLOOD PRESS (2001)

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

Staessen JA; Thijs L; Fagard R; Celis H; Birgenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Forette F; Leonetti G; McCormack P; Nachev C; O'Brien E; Rodicio JL; Rosenfeld J; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Zanchetti A; TheSys-Eur Trial Investigators
J Hypertens (2004)

Influence of hypotensive drug treatment in elderly hypertensives: Study terminated events in the trial of the European Working Party on High Blooc Pressure in the Elderely

Amery A; Birkenhäger W; Brixko P; Bulpitt C; Clement D; De Leeuw P; De Plaen JF; Deruyttere M; De Schaepdryver A; Dollery C; Fagard R; Feltkamp H; Forette F; Forte J; Hamdy R; Henry JF; Joossens JV; Koistinen A; Leonetti G; Lund-Johansen P; Morris J; Nissinen A; O'Brien E; O'Malley K; Pelemans W; Strasser T; Tuomilehto J; Webster J; Zanchetti A
J Hypertens : suppl 3 (1985)

Influence of hypotensive drug treatment in elderly hypertensives: study terminated events in the trial of the European Working Party on High Blood Pressure in the Elderly

Amery A; Birkenhäger W; Brixko P; Bulpitt C; Clement D; De Leeuw P; De Plaen JF; Deruyttere M; De Schaepdryver A; Dollery C; Fagard R; Feltkamp H; Forette F; Forte J; Hamdy R; Henry JF; Joossens JV; Koistinen A; Leonetti G; Lund-Johansen P; Morris J; Nissinen A; O'Brien E; O'Malley K; Pelemans W; Strasser T; Tuomilehto J; Webster J; Zanchetti A
Lancet : June 15 (1985)

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Julius S; Kjeldsen SE; Weber M; Brunner HR; Ekman S; Hansson L; Hua T; Laragh J; McInnes GT; Mitchell L; Plat F; Schork A; Smith B; Zanchetti A; the VALUE trial group; Tuomilehto J
Lancet (2004)

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Staessen JA; Fagard R; Thijs L; Arabidze GG; Birkenhänger WH; Bulpitt CJ; de Leeuw P; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A; for the Syst-Eur Trial Investigators; Sarti C
Lancet (1997)

Subgroup and Pre-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly

Staessen JA; Fagard R; Thijs L; Celis H; Birkenhager WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene M-R; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A; for the Systolic Hypertension in Europe Trial Investigators; Sarti C
Arch Intern Med (1998)

Artikkelit - Selaus tekijän mukaan "Zanchetti A"

Age-related effects of placebo and active treatment in patients beyond the age of 60 years: the need for a proper control group ﻿

An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization ﻿

Characteristics of 15 314 hypertensive patients at high coronary risk. The VALUE Trial ﻿

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial ﻿

Influence of hypotensive drug treatment in elderly hypertensives: Study terminated events in the trial of the European Working Party on High Blooc Pressure in the Elderely ﻿

Influence of hypotensive drug treatment in elderly hypertensives: study terminated events in the trial of the European Working Party on High Blood Pressure in the Elderly ﻿

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial ﻿

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension ﻿

Subgroup and Pre-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly ﻿